Works matching IS 16655044 AND DT 2020 AND VI 21 AND IP 3

Results: 6
    1
    2
    3

    Clinical considerations on the introduction of ocrelizumab in Mexico.

    Published in:
    Revista Mexicana de Neurociencia, 2020, v. 21, n. 3, p. 97, doi. 10.24875/RMN.20000153
    By:
    • Ordoñez-Boschetti, Laura;
    • Velázquez-Quintana, Merced;
    • Skromne-Eisenberg, Eli;
    • Treviño-Frenk, Irene;
    • Rivas-Alonso, Verónica;
    • Bertado-Cortes, Brenda;
    • De la Maza-Flores, Manuel;
    • Quiñones-Aguilar, Sandra;
    • Amaya-Sánchez, Luis;
    • Llamas-López, Leonardo;
    • Gonzalez-Amezquita, Victor ~
    Publication type:
    Article
    4

    Executive dysfunction in middle-aged hypertensive adults.

    Published in:
    Revista Mexicana de Neurociencia, 2020, v. 21, n. 3, p. 90, doi. 10.24875/rmn.20000126
    By:
    • Palma-Díaz, Edwin J.;
    • Estrella-Castillo, Damaris F.;
    • Zapata-Vázquez, Rita E.;
    • García-Santamaría, Edgar;
    • Rubio Zapata, Héctor A.
    Publication type:
    Article
    5
    6

    Nervous system and COVID-19.

    Published in:
    Revista Mexicana de Neurociencia, 2020, v. 21, n. 3, p. 80, doi. 10.24875/RMN.M20000079
    By:
    • Torres-Oliva, Bertha;
    • Vélez-Jiménez, Karina;
    • Rodríguez-Leyva, Idelfonso;
    • Guerrero-Torres, Lorena
    Publication type:
    Article